Clinical trial
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast…
NCT00010010 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00010010 |
|---|---|
| Title | Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer |
| Official title | A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | exemestane, goserelin acetate |
| Start date | Jun 1, 2000 |
| Primary completion | May 1, 2001 |
| First posted | Apr 21, 2004 |
| Last update posted | Mar 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: